Bioresorbable vascular scaffold (BVS) for in-stent chronic total occlusion: Antegrade recanalization and IVUS-guided BVS implantation by radial access

Cardiovasc Revasc Med. 2016 Jan-Feb;17(1):63-5. doi: 10.1016/j.carrev.2015.12.003. Epub 2015 Dec 23.

Abstract

The completely absorbable stents represent one of the latest innovations in the field of interventional cardiology, prospecting the possibility of "vascular repair". In the published trials (ABSORB Cohort A and B, ABSORB EXTEND, and ABSORB II, III and IV) chronic total occlusions (CTOs) were considered an exclusion criteria. More recently the CTO-ABSORB pilot study demonstrated the safety and feasibility of bioresorbable vascular scaffold (BVS) use in case of CTO recanalization. We present the first case, to our knowledge, of in-stent occlusion successfully treated with an everolimus-eluting BVS and discuss its potential advantages in such kind of lesions.

Keywords: Bioresorbable vascular scaffold (BVS) implantation; Chronic total occlusion (CTO); Intravascular ultrasound (IVUS); Restenosis.

Publication types

  • Case Reports

MeSH terms

  • Absorbable Implants*
  • Chronic Disease
  • Coronary Angiography
  • Drug-Eluting Stents*
  • Everolimus / therapeutic use
  • Graft Occlusion, Vascular / diagnostic imaging*
  • Graft Occlusion, Vascular / therapy*
  • Humans
  • Male
  • Middle Aged
  • Prosthesis Design
  • Radial Artery / diagnostic imaging
  • Treatment Outcome
  • Ultrasonography, Interventional / methods*

Substances

  • Everolimus